益佰制药(600594.SH)：预计2025年度归母净利润为负值

Core Viewpoint - Yibai Pharmaceutical (600594.SH) is expected to report a negative net profit attributable to shareholders for the fiscal year 2025, indicating an operational loss for the company [1] Financial Performance - The company’s financial department has conducted preliminary calculations, forecasting a loss for the fiscal year 2025 [1] - Yibai Pharmaceutical will adhere to the regulations set forth by the Shanghai Stock Exchange and expedite its financial accounting processes [1] - The final financial data will be based on the officially disclosed audited annual report for 2025 [1]